Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX

Surgical Endoscopy

Volumn 25, Issue 1, 2011, Pages 305-308

  Liang, Jin Tung ^a   Lai, Hong Shiee ^a   Cheng, Kuo Wei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bevacizumab; CCRT; FOLFOX; Laparoscopic surgery; Rectal cancer

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONVALESCENCE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ENTEROCUTANEOUS FISTULA; FATTY LIVER; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LAPAROSCOPIC TOTAL MESORECTAL EXCISION; LIVER SINUSOID; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; PATIENT SAFETY; PELVIS ABSCESS; PERINEUM INJURY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; SIDE EFFECT; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT RESPONSE; UPPER GASTROINTESTINAL BLEEDING;

EID: 79251620917     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-010-1125-8     Document Type: Article

References (16)

1. HI Hurwitz J Yi W Ince WF Novotny O Rosen 2009 The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of k-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer Oncologist 14 22 28 1:CAS:528:DC%2BD1MXjt1Clt7o%3D 10.1634/theoncologist.2008-0213 19144677
2. B Gruenberger D Tamandl J Schueller W Scheithauer C Zielinski F Herbst T Gruenberger 2008 Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 1830 1835 1:CAS:528:DC%2BD1cXmsFemsbg%3D 10.1200/JCO.2007.13.7679 18398148
3. HM Quah JF Chou M Gonen J Shia D Schrag LB Saltz KA Goodman BD Minsky WD Wong MR Weiser 2008 Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Cancer 113 57 64 10.1002/cncr.23516 18442099 (Pubitemid 351976386)
4. CG Willett Y Boucher E di Tomaso DG Duda LL Munn RT Tong DC Chung DV Sahani SP Kalva SV Kozin M Mino KS Cohen DT Scadden AC Hartford AJ Fischman JW Clark DP Ryan AX Zhu LS Blaszkowsky HX Chen PC Shellito GY Lauwers RK Jain 2004 Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 145 147 1:CAS:528: DC%2BD2cXoslKmtQ%3D%3D 10.1038/nm988 14745444 (Pubitemid 38524883)
5. CG Willett DG Duda E di Tomaso Y Boucher BG Czito Z Vujaskovic G Vlahovic J Bendell KS Cohen HI Hurwitz R Bentley GY Lauwers M Poleski TZ Wong E Paulson KA Ludwig RK Jain 2007 Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer Nat Clin Pract Oncol 4 316 321 1:CAS:528:DC%2BD2sXks1ynur0%3D 10.1038/ncponc0813 17464339 (Pubitemid 46758789)
6. JT Liang HS Lai PH Lee 2006 Laparoscopic total mesorectal excision for rectal cancer Dis Colon Rectum 49 517 518 10.1007/s10350-005-0325-0
7. JT Liang KC Huang HS Lai PH Lee YM Jeng 2007 Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: a randomized controlled trial Ann Surg Oncol 14 109 117 10.1245/s10434-006-9135-4 17066227 (Pubitemid 44954277)
8. RJ Heald EM Husband RD Ryall 1982 The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 69 613 616 1:STN:280:DyaL3s%2Fitl2nsw%3D%3D 10.1002/bjs.1800691019 6751457 (Pubitemid 12038080)
9. JT Liang HS Lai PH Lee 2006 Laparoscopic abdominoanal pull-through procedure for male patients with lower rectal cancer after chemoradiation therapy Dis Colon Rectum 49 259 260 10.1007/s10350-005-0250-2 16228818 (Pubitemid 43219964)
10. JT Liang HS Lai PH Lee 2006 Laparoscopic abdominoperineal resection for lower rectal cancers: how we do it? Surg Endosc 20 695 696 10.1007/s00464-005- 0460-7 16502195
11. S Kandutsch M Klinger S Hacker F Wrba B Gruenberger T Gruenberger 2008 Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases EJSO 34 1231 1236 1:STN:280:DC%2BD1cnos1yjtQ%3D%3D 18272318
12. C Rödel P Martus T Papadoupolos L Füzesi M Klimpfinger R Fietkau T Liersch W Hohenberger R Raab R Sauer C Wittekind 2005 Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 8688 8696 10.1200/JCO.2005.02.1329 16246976 (Pubitemid 46211512)
13. JF Bosset L Collette G Calais L Mineur P Maingon L Radosevic-Jelic A Daban E Bardet A Beny JC Ollier EORTC Radiotherapy Group Trial 22921 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114 1123 1:CAS:528:DC%2BD28XpsFKkur8%3D 10.1056/NEJMoa060829 16971718 (Pubitemid 44394918)
14. Clinical Outcomes of Surgical Therapy Study Group 2004 A comparison of laparoscopically assisted and open colectomy for colon cancer N Engl J Med 350 2050 2059 10.1056/NEJMoa032651 (Pubitemid 38596556)
15. JT Poon WL Law 2009 Laparoscopic resection for rectal cancer: a review Ann Surg Oncol 16 3038 3047 10.1245/s10434-009-0603-5 19641971
16. DP Ryan D Niedzwiecki D Hollis BE Mediema S Wadler JE Tepper RM Goldberg RJ Mayer Cancer and Leukemia Group B 89901 2006 Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukemia group B 89901 J Clin Oncol 24 2557 2562 1:CAS:528:DC%2BD28XmtVOmt78%3D 10.1200/JCO.2006.05.6754 16636336 (Pubitemid 46630634)